Alimera Sciences down on filing lawsuit against ANI Pharma to close deal
** Shares of eye drug developer Alimera Sciences ALIM.O
fall 16.67% to $4.61
** Co files lawsuit to compel ANI Pharmaceuticals ANIP.O
to close merger transaction
** The lawsuit asks the court to require ANI to comply with
its obligations to complete the transaction as contemplated by
the agreement
** The companies announced their agreement in June, valuing
ALIM at about $381 mln in upfront consideration
** ALIM up ~6% YTD
(Reporting by Sriparna Roy in Bengaluru)
((Sriparna.Roy@thomsonreuters.com;))
Recent news on Alimera Sciences
See all newsBrief: ANI Pharmaceuticals And Alimera Sciences Announce Closing Date Of Merger
Brief: Ani Pharmaceuticals Provides Update On Closing Of Acquisition Of Alimera Sciences
U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms
U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma
Brief: Alimera Sciences Files Lawsuit To Compel ANI To Close Merger